Skip to main content
. 2018 Mar 5;9(22):16197–16204. doi: 10.18632/oncotarget.24610

Table 2. Significance of risk factors on OS, number of 223Ra treatment cycles and HT (respective P values are given).

<20 vs >20 bone mets CHT RT
OS 0.32 0.77 0.65
number of 223Ra cycles 0.14 0.44 0.12
HT 0.32 0.8 0.32